Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Kathleen Dungan MD, MPH
Kathleen M. Dungan MD, MPH Advisory Board
Silvio Inzucchi MD
Silvio E. Inzucchi MD Editor-in-Chief
Deborah Wexler MD, MSc
Deborah J. Wexler MD, MSc Associate Editor
See All Experts
featured
Published in Diabetes

Journal Scan / Research · January 05, 2023

Urine LRG1 Levels and the Risk of Progression to ESKD in Patients With Type 2 Diabetes

Diabetes Care

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Chirag Parikh MD, PhD, FACP

Nityasree Srialluri MD, MS

Diabetes Care
Urine Leucine-Rich α-2 Glycoprotein 1 (LRG1) Predicts the Risk of Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes
Diabetes Care 2022 Dec 14;[EPub Ahead of Print], JJ Liu, S Liu, J Wang, SLT Pek, J Lee, RL Gurung, K Ang, YM Shao, S Tavintharan, WE Tang, CF Sum, SC Lim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated